ArticleEuropean journal of pediatrics2025
Targeted congenital cytomegalovirus screening as part of the newborn hearing screening programme in Northeast England.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neonates with congenital CMV (cCMV) with hearing loss at birth have improved hearing and developmental outcomes when treatment is started within the first 4 weeks of life. This report retrospectively evaluates the performance of a targeted diagnostic pathway for 'otherwise well' neonates who fail their newborn hearing screen. Approximately 10% of 'otherwise well' neonates who failed their newborn hearing screen and were subsequently diagnosed with sensorineural hearing loss were identified as having cCMV, highlighting the pathway's diagnostic utility. Our findings do, however, identify a missed subgroup-infants with complex medical needs requiring prolonged neonatal hospital stays-who are often referred for audiology assessment too late for timely cCMV testing. These findings support the need to optimise early referral pathways to ensure that all at-risk neonates are offered diagnostic cCMV testing within the recommended time frame.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.